Martin Maisenhölder
Førsteamanuensis
Sirpa Leppä,
Judit Jørgensen,
Anne Tierens,
Leo Meriranta,
Ingunn Østlie,
Peter de Nully Brown
m.fl.:
Patients with high-risk DLBCL benefit from dose-dense immunochemotherapy combined with early systemic CNS prophylaxis
Viola Poeschel,
Gerhard Held,
Marita Ziepert,
Mathias Witzens-Harig,
Harald Holte,
Lorenz Thurner
m.fl.:
Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER): a randomised, phase 3, non-inferiority trial
The Lancet 2019 DOI
Sandra Lockmer,
Bjørn Østenstad,
Hans Hagberg,
Harald Holte,
Ann-Sofie Johansson,
Björn Engelbrekt Wahlin
m.fl.:
Chemotherapy-free initial treatment of advanced indolent lymphoma has durable effect with low toxicity: Results from two Nordic lymphoma group trials with more than 10 years of follow-up
Journal of Clinical Oncology 2018 DOI
Knut Bjøro Smeland,
Cecilie E. Kiserud,
Grete Fossum Lauritzsen,
Anne Kirsti Blystad,
Unn-Merete Fagerli,
Ragnhild Sørum Falk
m.fl.:
A national study on conditional survival, excess mortality and second cancer after high dose therapy with autologous stem cell transplantation for non-Hodgkin lymphoma
British Journal of Haematology 2016 DOI
Knut Halvor Bjøro Smeland,
Cecilie E. Kiserud,
Grete Fossum Lauritzsen,
Unn-Merete Fagerli,
Ragnhild Sørum Falk,
Øystein Fluge
m.fl.:
Conditional survival and excess mortality after high-dose therapy with autologous stem cell transplantation for adult refractory or relapsed Hodgkin lymphoma in Norway
Knut Halvor Bjøro Smeland,
Cecilie E. Kiserud,
Grete Fossum Lauritzsen,
Anne Kirsti Blystad,
Unn-Merete Fagerli,
Øystein Fluge
m.fl.:
High dose therapy with autologous stem cell support for lymphoma in Norway 1987-2008
Tidsskrift for Den norske legeforening 2013 DOI
Knut Bjøro Smeland,
Cecilie E. Kiserud,
Grete Fossum Lauritzsen,
Anne Kirsti Blystad,
Unn Merete Fagerli,
Øystein Fluge
m.fl.:
Høydosebehandling med autolog stamcellestøtte ved lymfom i Norge 1987 - 2008
Tidsskrift for Den norske legeforening 2013 DOI
Viggo Jønsson,
Haneef Awan,
Emil Nyquist,
Martin Maisenhölder,
Tom Børge Johannesen,
Bernt Erik Ly
m.fl.:
Familial Hodgkin's Lymphoma in Scandinavia
In Vivo 2011 FULLTEKST
Björn Engelbrekt Wahlin,
Christer Sundström,
Harald Holte,
Hans Hagberg,
Martin Erlanson,
Herman Nilsson-Ehle
m.fl.:
T Cells in Tumors and Blood Predict Outcome in Follicular Lymphoma Treated with Rituximab
Clinical Cancer Research 2011 DOI
Marianne Brodtkorb Eide,
Grete Fossum Lauritzsen,
Gunnar Kvalheim,
Arne Kolstad,
Unn-Merete Fagerli,
Martin Maisenhölder
m.fl.:
High dose chemotherapy with autologous stem cell support for patients with histologically transformed B-cell non-Hodgkin lymphomas. A Norwegian multi centre phase II study
British Journal of Haematology 2011 DOI
De 50 siste resultatene fra Cristin vises på siden. Se alle arbeider i Cristin her →